XML 22 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Accrued Expenses and Other Current Liabilities

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

9. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

		March 31, 2024				December 31, 2023
Accrued clinical study and trial costs		$	18,110			$	16,346
Accrued compensation and related costs			4,567				11,172
Accrued professional fees			1,642				1,450
Accrued milestone costs			8,000				10,000
Other			1,076				888
Total accrued expenses and other current liabilities		$	33,395			$	39,856

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

No definition available.

+ Details

Name:	us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration